310 related articles for article (PubMed ID: 1593220)
21. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of Wilson's disease with zinc. 5 cases].
Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
[TBL] [Abstract][Full Text] [Related]
23. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
Dastych M; Procházková D; Pokorný A; Zdrazil L
Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
[TBL] [Abstract][Full Text] [Related]
24. The development of cirrhosis in Wilson's disease.
Sternlieb I
Clin Gastroenterol; 1975 May; 4(2):367-79. PubMed ID: 1092490
[No Abstract] [Full Text] [Related]
25. Zinc therapy in Wilson's disease: observations in five patients.
Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
[TBL] [Abstract][Full Text] [Related]
26. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
Sato M; Hayashi A; Ito H; Tojo M; Arima M
No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
[TBL] [Abstract][Full Text] [Related]
27. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
28. Interactions of zinc and molybdenum with copper in therapy of Wilson's disease.
Brewer GJ
Nutrition; 1995; 11(1 Suppl):114-6. PubMed ID: 7749256
[TBL] [Abstract][Full Text] [Related]
29. The effect of gold on copper and zinc in kidney and in metallothionein.
Saito S
Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):171-6. PubMed ID: 8884988
[TBL] [Abstract][Full Text] [Related]
30. [True hepatic Wilson's disease].
Ciravegna B; Giacchino R; Marazzi MG
Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
[TBL] [Abstract][Full Text] [Related]
31. Interaction between copper and zinc in metal accumulation in rats with particular reference to the synthesis of induced-metallothionein.
Irato P; Albergoni V
Chem Biol Interact; 2005 Aug; 155(3):155-64. PubMed ID: 16083871
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
[TBL] [Abstract][Full Text] [Related]
33. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
34. Interactions between Zn and Cu in LEC rats, an animal model of Wilson's disease.
Santon A; Giannetto S; Sturniolo GC; Medici V; D'Incà R; Irato P; Albergoni V
Histochem Cell Biol; 2002 Mar; 117(3):275-81. PubMed ID: 11914925
[TBL] [Abstract][Full Text] [Related]
35. [Abnormal hepatic copper accumulation and its significance in LEC rats developing spontaneous hepatitis and hepatoma].
Li Y
Hokkaido Igaku Zasshi; 1991 Sep; 66(5):658-64. PubMed ID: 1959841
[TBL] [Abstract][Full Text] [Related]
36. Copper metabolism in LEC rats aged 30 and 80 days old: induction of Cu-metallothionein and status of zinc and iron.
Sugawara N; Sugawara C; Sato M; Katakura M; Takahashi H; Mori M
Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):353-62. PubMed ID: 1947438
[TBL] [Abstract][Full Text] [Related]
37. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
Schilsky M
Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
[No Abstract] [Full Text] [Related]
38. [The role of zinc in the initial treatment of Wilson's disease in children].
Cacić M; Percl M; Jadresin O; Kolacek S
Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
[TBL] [Abstract][Full Text] [Related]
39. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
[TBL] [Abstract][Full Text] [Related]
40. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
